By JORGO CHATZIMARKAKIS
Around the world and now in the United States, there is a broadening discussion of how best to proceed down the path of approving and getting to market medicines called biosimilars. Biosimilars are non-identical copies of next
Read More...
Read the complete post at http://thehealthcareblog.com/blog/2011/05/18/when-it-comes-to-patient-safety/
Posted
May 18 2011, 02:59 PM
by
The Health Care Blog